Impact of fluconazole administration on outcomes in critically ill patients

被引:5
|
作者
Garrelts, JC
Schroeder, TR
Harrison, PB
机构
[1] Wesley Med Ctr, Clin Pharm Serv & Res, Wichita, KS 67214 USA
[2] Wesley Med Ctr, Infect Dis, Wichita, KS 67214 USA
[3] Wesley Med Ctr, Trauma Program, Wichita, KS 67214 USA
关键词
fluconazole; outcomes; trauma;
D O I
10.1345/aph.1D441
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Serious infections caused by Candida spp. are an increasingly important cause of morbidity and mortality in critically ill patients. it is unclear which patients will benefit from therapy and at what point to institute treatment. OBJECTIVE: To evaluate the impact of administration of fluconazole therapy in critically ill trauma patients on mortality, length of hospital stay, incidence of deep-seated fungal infection, and positive fungal cultures from any site. METHODS: We conducted a retrospective, matched case-control study of 116 critically ill surgical trauma patients who did or did not receive fluconazole. Patients were followed until hospital discharge or death. A consecutive sample of 58 patients who received fluconazole was selected. A parallel group of patients was evaluated, from which 58 were matched with fluconazole-treated patients based on age (+/-5 y), gender, and APACHE II score (+/- 3). RESULTS: The groups of patients were well matched, with the exception of central venous catheter placement and broad-spectrum antibiotic use. We found no difference between groups in hospital mortality (21% vs 26%; p = 0.661) or incidence of deep-seated fungal infection (0% vs 2%; p = NS). However, patients receiving fluconazole had a significantly longer stay in both the intensive care unit (ICU) (18 +/- 13 vs 7 +/- 11 days; p < 0.001) and hospital (25 +/- 15 vs 9 +/- 11 days; p < 0.001). Fluconazole patients were significantly more likely to have Candida cultured from sites associated with colonization (43% vs 2%; p < 0.001), possibly explaining why they received fluconazole. CONCLUSIONS: We were unable to detect a benefit from use of fluconazole in our surgical trauma patient population. Isolation of Candida from the mouth or throat alone, in the absence of correlating clinical signs of infection, should not lead to initiation of fluconazole therapy. Fluconazole use should be reserved for carefully selected patients in the trauma ICU setting.
引用
收藏
页码:1588 / 1592
页数:5
相关论文
共 50 条
  • [41] Association between furosemide administration and outcomes in critically ill patients with acute kidney injury
    Guang-ju Zhao
    Chang Xu
    Jian-chao Ying
    Wen-biao Lü
    Guang-liang Hong
    Meng-fang Li
    Bing Wu
    Yong-ming Yao
    Zhong-qiu Lu
    Critical Care, 24
  • [42] Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury
    Luo, Xinyao
    Zhou, Weijian
    Wan, Dingyuan
    Peng, Jing
    Liao, Ruoxi
    Su, Baihai
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
    Smith, Susan E. E.
    Halbig, Zachary
    Fox, Nicholas R. R.
    Bland, Christopher M. M.
    Branan, Trisha N. N.
    ANTIBIOTICS-BASEL, 2023, 12 (06):
  • [44] Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia
    Theodore, Deborah A.
    Henneman, Amrita D.
    Loo, Angela
    Shields, Ryan K.
    Eschenauer, Gregory
    Sobieszczyk, Magdalena E.
    Kubin, Christine J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 1877 - 1884
  • [45] Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
    Boonstra, J. M.
    Martson, A. G.
    Sandaradura, I
    Kosterink, J. G. W.
    van der Werf, T. S.
    Marriott, D. J. E.
    Zijlstra, J. G.
    Touw, D. J.
    Alffenaar, J. W. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)
  • [46] EVALUATION OF DIURETIC USE AND IMPACT ON RESPIRATORY OUTCOMES IN CRITICALLY ILL TRAUMA PATIENTS
    Holmes, Sydney
    Weitkamp, Lindsay
    Scherrer, Leigh Ann
    Cox, Mark
    Nash, Nicholas
    CRITICAL CARE MEDICINE, 2024, 52
  • [47] Echocardiographic Findings and Their Impact on Outcomes of Critically Ill Patients with AIDS in the Era of HAART
    Bajwa, Abubakr A.
    Cury, James D.
    Jones, Lisa
    Shujaat, Adil
    Usman, Faisal
    PULMONARY MEDICINE, 2012, 2012
  • [48] Impact of body temperature and serum procalcitonin on the outcomes of critically ill neurological patients
    Feasal, Abeer
    El Azab, Abdou
    Mashhour, Karim
    El Hadidy, Amr
    EGYPTIAN JOURNAL OF CRITICAL CARE MEDICINE, 2015, 3 (01): : 1 - 8
  • [49] Prognostic Impact of Early Administration of β-Blockers in Critically Ill Patients with Acute Myocardial Infarction
    Zhang, Chong
    Wang, Fei
    Hao, Cuijun
    Liang, Weiru
    Hou, Tianhua
    Xin, Jiayan
    Su, Bin
    Ning, Meng
    Liu, Yingwu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (04): : 410 - 417
  • [50] Extreme Obesity and Outcomes in Critically Ill Patients
    Martino, Jenny L.
    Stapleton, Renee D.
    Wang, Miao
    Day, Andrew C.
    Cahill, Naomi E.
    Dixon, Anne E.
    Suratt, Benjamin T.
    Heyland, Daren K.
    CHEST, 2011, 140 (05) : 1198 - 1206